EUVIMEDEUVIMED entdecken
Crossref

Development of Proniosomal Dry Powder for Dual Pulmonary Delivery of Salbutamol Sulfate and Carvacrol: A Design of Experiment Approach

Deepa Neopane, Poonam Kushwaha, Badruddeen

Pharmaceutical Research · 2026

DOI: 10.1007/s11095-026-04042-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Research, 2026. Verfasst von Deepa Neopane und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, 226026, India. Hauptthemen laut MEDLINE: Albuterol, Monoterpenes. Die Arbeit nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Proniosomes are dry, free-flowing, carrier-based systems designed to enhance pulmonary drug delivery and improve the aerosolization of therapeutic agents. Such systems are gaining attention for optimizing the performance of dry powder inhalers (DPIs) in inhalation therapy. OBJECTIVE: This study aimed to develop and optimize a proniosomal powder system for dual pulmonary delivery of Salbutamol sulfate (SS) and Carvacrol (CAR) using the Box-Behnken design (BBD). METHODS: Proniosomes were prepared by the slurry method. A three-factor, three-level BBD was employed to assess the influence of Span 60, lactose monohydrate, and mannitol concentrations on particle size, entrapment efficiency (% EE), and drug loading capacity (% LC). The optimized formulation was characterized by FTIR, XRD, and SEM to confirm drug-excipient compatibility, amorphous dispersion, and surface morphology. RESULTS: The optimized proniosomal powder exhibited desirable particle size (827.4 ± 33.65 nm), high drug entrapment (SS: 84.37 ± 2.04%; CAR: 95.5 ± 1.52%), and efficient aerosolization performance. FTIR and XRD results confirmed chemical compatibility and amorphous nature of the entrapped drugs. In vitro release studies indicated sustained drug release pattern (SS: 67.34%; CAR: 68.89% over 24 h). Stability studies over 6 months demonstrated a good shelf-life and retention of vesicle-forming capability upon hydration. CONCLUSION: The developed dual-drug proniosomal powder offers a promising approach for pulmonary drug delivery. Its optimized physicochemical and aerosolization characteristics suggest potential utility in the effective management of respiratory disorders through sustained release and improved lung deposition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlbuterolMonoterpenesDry Powder InhalersParticle SizeCymenesAdministration, InhalationPowdersExcipientsLactoseDrug Delivery SystemsAerosolsLungBronchodilator AgentsDrug CarriersChemistry, PharmaceuticalHexosesDrug LiberationMannitol

Stichwörter der Autor:innen

box–behnken designcarvacroldry powder inhalerproniosomespulmonary drug deliverysalbutamol sulfateslurry method

Substanzen

AlbuterolCymenescarvacrolPowdersExcipientsMonoterpenesLactoseAerosolsBronchodilator AgentsDrug Carriers

Autor:innen und Institutionen

  • Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, 226026, India.
  • Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, 226026, India. poonam@iul.ac.in.

Zitieren

APA

Neopane, D., Kushwaha, P., & Badruddeen (2026). Development of Proniosomal Dry Powder for Dual Pulmonary Delivery of Salbutamol Sulfate and Carvacrol: A Design of Experiment Approach. Pharmaceutical Research. https://doi.org/10.1007/s11095-026-04042-2

Vancouver

Neopane D, Kushwaha P, Badruddeen. Development of Proniosomal Dry Powder for Dual Pulmonary Delivery of Salbutamol Sulfate and Carvacrol: A Design of Experiment Approach. Pharmaceutical Research. 2026. doi:10.1007/s11095-026-04042-2

BibTeX
@article{Neopane2026,
  author = {Neopane, Deepa and Kushwaha, Poonam and Badruddeen},
  title = {Development of Proniosomal Dry Powder for Dual Pulmonary Delivery of Salbutamol Sulfate and Carvacrol: A Design of Experiment Approach},
  journal = {Pharmaceutical Research},
  year = {2026},
  doi = {10.1007/s11095-026-04042-2}
}
Kostenlos starten →